JOHN K FINK, MD
Neurology in Ann Arbor, MI
License number
Michigan 4301056476
Category
Neurology
Type
Neurology
Address
Address
1500 Floor Taubman Ctr, Ann Arbor, MI 48109
Phone
(734) 936-9010
(734) 936-2047
(734) 936-2047
Personal information
See more information about JOHN K FINK at radaris.comName
Address
Phone
4648 Morley Dr, Vicksburg, MI 49097
4709 Pine Oak Ct, Hudsonville, MI 49426
5188 Hansen Dr, Swartz Creek, MI 48473
406 N Main St, Yale, MI 48097
2361 Placid Way, Ann Arbor, MI 48105
Professional information
See more information about JOHN K FINK at trustoria.com
Dr. John K Fink, Ann Arbor MI - MD (Doctor of Medicine)
Dr. John K Fink, Ann Arbor MI - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Neurology), Clinical Genetics
Address:
UM Adult Neurology Outptnt Svcs
1500 E Medical Center Dr SUITE 1324, Ann Arbor 48109
(734) 936-9020 (Phone)
1500 E Medical Center Dr SUITE 1324, Ann Arbor 48109
(734) 936-9020 (Phone)
Certifications:
Clinical Genetics, 1990, Neurology, 1985
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Toledo
Graduated: 1980
Mayo Clinic-Rochester
U Va Coll Med
National Institutes Of Health Clinical Center
University of Toledo
Graduated: 1980
Mayo Clinic-Rochester
U Va Coll Med
National Institutes Of Health Clinical Center
John K Fink, Ann Arbor MI
John K Fink, Ann Arbor MI
Specialties:
Neurologist
Address:
1500 E Medical Center Dr, Ann Arbor, MI 48109
Education:
Medical College Ohio, Toledo - Doctor of Medicine
Board certifications:
American Board of Medical Genetics Certification in Clinical Genetics (MD) (Medical Genetics), American Board of Psychiatry and Neurology Certification in Neurology (Psychiatry and Neurology)
Compositions And Methods For Detecting And Treating Motor Neuron Disorders
Compositions And Methods For Detecting And Treating Motor Neuron Disorders
US Patent:
7384748, Jun 10, 2008
Filed:
Dec 13, 2005
Appl. No.:
11/301524
Inventors:
John K. Fink - Ann Arbor MI, US
Shirley Rainer - Sylvania OH, US
Shirley Rainer - Sylvania OH, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
C12Q 1/68, C12Q 1/00, G01N 33/566, G01N 33/567
US Classification:
435 6, 435 4, 436501, 436503, 436504, 536 243
Abstract:
The present invention relates to the NTE proteins and nucleic acids encoding the NTE proteins. The present invention further provides assays for the detection of NTE polymorphisms and mutations associated with disease states, as well as methods of screening for ligands and modulators of NTE proteins.
Compositions And Methods For Detecting And Treating Neurological Conditions
Compositions And Methods For Detecting And Treating Neurological Conditions
US Patent:
7332282, Feb 19, 2008
Filed:
Aug 19, 2004
Appl. No.:
10/921742
Inventors:
John K. Fink - Ann Arbor MI, US
Shirley Rainier - Sylvania OH, US
Robert D. Nicholls - Philadelphia PA, US
Jinghua Chai - Ardmore PA, US
Shirley Rainier - Sylvania OH, US
Robert D. Nicholls - Philadelphia PA, US
Jinghua Chai - Ardmore PA, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
C07H 21/04, C12Q 1/68
US Classification:
435 6, 435 911, 435 912, 536 231, 536 243
Abstract:
The present invention relates to the NIPA-1 proteins and nucleic acids encoding the NIPA-1 proteins. The present invention further provides assays for the detection of NIPA-1 polymorphisms and mutations associated with disease states, as well as methods of screening for ligands and modulators of NIPA-1 proteins.
Compositions And Methods For Detecting And Treating Neurological Conditions
Compositions And Methods For Detecting And Treating Neurological Conditions
US Patent:
8518638, Aug 27, 2013
Filed:
Feb 7, 2008
Appl. No.:
12/027834
Inventors:
John K. Fink - Ann Arbor MI, US
Shirley Rainier - Sylvania OH, US
Robert D. Nicholls - Philadelphia PA, US
Jinghua Chai - Ardmore PA, US
Shirley Rainier - Sylvania OH, US
Robert D. Nicholls - Philadelphia PA, US
Jinghua Chai - Ardmore PA, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
C07H 21/04, C12Q 1/68
US Classification:
435 61, 435 611, 435 612, 435 911, 435 912, 536 231, 536 243
Abstract:
The present invention relates to the NIPA-1 proteins and nucleic acids encoding the NIPA-1 proteins. The present invention further provides assays for the detection of NIPA-1 polymorphisms and mutations associated with disease states, as well as methods of screening for ligands and modulators of NIPA-1 proteins.
Methods For Diagnosing Episodic Movement Disorders And Related Conditions
Methods For Diagnosing Episodic Movement Disorders And Related Conditions
US Patent:
8481260, Jul 9, 2013
Filed:
Mar 23, 2010
Appl. No.:
12/729773
Inventors:
John K. Fink - Ann Arbor MI, US
Shirley Rainier - Sylvania OH, US
Shirley Rainier - Sylvania OH, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
C12Q 1/00
US Classification:
435 61
Abstract:
The present invention provides compositions and methods for research, diagnostic, drug screening, and therapeutic applications related to paroxysmal dystonic choreoathetosis and related conditions. In particular, the present invention provides mutations in the myofibrillogenesis regulator 1 (MR-1) gene associated with such conditions.
Methods For Diagnosing Episodic Movement Disorders And Related Conditions
Methods For Diagnosing Episodic Movement Disorders And Related Conditions
US Patent:
7727719, Jun 1, 2010
Filed:
Jun 27, 2005
Appl. No.:
11/167838
Inventors:
John K. Fink - Ann Arbor MI, US
Shirley Rainier - Sylvania OH, US
Shirley Rainier - Sylvania OH, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
C12Q 1/00
US Classification:
435 6
Abstract:
The present invention provides compositions and methods for research, diagnostic, drug screening, and therapeutic applications related to paroxysmal dystonic choreoathetosis and related conditions. In particular, the present invention provides mutations in the myofibrillogenesis regulator 1 (MR-1) gene associated with such conditions.
Atlastin
Atlastin
US Patent:
2009021, Aug 27, 2009
Filed:
Mar 27, 2009
Appl. No.:
12/412981
Inventors:
John K. Fink - Ann Arbor MI, US
Xinping Zhao - Houston TX, US
Xinping Zhao - Houston TX, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The present invention relates to methods and compositions of a novel gene and the peptide encoded by the gene. Mutations in the gene, named atlastin, are factors in the disease Hereditary Spastic Paraplegia and related disorders. The present invention will be used for the in the research, diagnosis and treatment of these disabling diseases.
Atlastin
Atlastin
US Patent:
7108975, Sep 19, 2006
Filed:
Sep 12, 2002
Appl. No.:
10/242008
Inventors:
John K. Fink - Ann Arbor MI, US
Xinping Zhao - Houston TX, US
Xinping Zhao - Houston TX, US
Assignee:
Regents of the University of Michigan - Ann Arbor MI
International Classification:
C12Q 1/68, C07H 21/04
US Classification:
435 6, 536 235, 536 2431
Abstract:
The present invention relates to methods and compositions of a novel gene and the peptide encoded by the gene. Mutations in the gene, named atlastin, are factors in the disease Hereditary Spastic Paraplegia and related disorders. The present invention will be used for the in the research, diagnosis and treatment of these disabling diseases.
Atlastin
Atlastin
US Patent:
7582425, Sep 1, 2009
Filed:
Feb 11, 2003
Appl. No.:
10/364748
Inventors:
John K. Fink - Ann Arbor MI, US
Xinping Zhao - Houston TX, US
Xinping Zhao - Houston TX, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
C12Q 1/68, C12P 19/34, C07H 21/02, C07H 21/04
US Classification:
435 6, 435 912, 536 231, 536 235, 536 2431, 536 2433
Abstract:
The present invention relates to methods and compositions of a novel gene and the peptide encoded by the gene. Mutations in the gene, named atlastin, are factors in the disease Hereditary Spastic Paraplegia and related disorders. The present invention will be used for the in the research, diagnosis and treatment of these disabling diseases.